Vesper
IND-7742Tirzepatide · 12.5 mg weeklyCycle day 4 of 7Pen in range

Signals · 14 days

Self-reported

Energy

7.8/ 10

up 2.4 over the fortnight

Appetite

3.1/ 10

steady since the step to 12.5

Sleep

7.5hrs

five nights over seven hours

Nausea

0.6/ 10

two flat days after the last dose

ThuFriSatSunMonTueWed3d 14huntil dose 15

Next dose

Thursday, 20:00

Site

Right abdomen

Last time

Left abdomen

Weight

Week 14

198.4lb

−33.4 lb since 231.8

Titration

mg · weekly

2.5
5.0
7.5
10.0
12.5
15.0

One step left. It is not automatic — it is decided at the week 20 review.

Log · last 24 hours

20:04

Dose logged

12.5 mg · left abdomen · pen 03

07:12

Weight recorded

198.4 lb · before food

22:40

Sleep synced

7 h 51 m · from watch

13:05

Check-in complete

No side effects reported

09:30

Shipment dispatched

4 pens · arrives Fri 20 Mar

About this project

Concept — 2026

VesperNight Console

Vesper is a concept GLP-1 patient portal organised around time instead of records. The centre of the screen is the seven-day dose cycle drawn as a ring that runs once a week rather than once a day: the lit arc is the cycle already spent, its head is now, and the seven ticks are the days between this dose and the next — all of it derived from one elapsed-over-total ratio, with no second copy of the truth anywhere. The rails carry fourteen-day traces of energy, appetite, sleep and nausea, a titration gauge with one step left, and a log of what actually happened, timestamped. Dark here means low light, not black chrome: panels are hairlines over a 4% wash, and exactly one luminous colour is allowed — lime marks the present moment and nothing else.

A concept project designed & built by Emre Gundogdu, a freelance front-end developer and web design & development partner.

Role
Design & Front-End Development
Year
2026
Stack
Next.js · React · TypeScript · GSAP · SVG